ALK-Abello A/S
CSE:ALK B

Watchlist Manager
ALK-Abello A/S Logo
ALK-Abello A/S
CSE:ALK B
Watchlist
Price: 223.8 DKK -0.97% Market Closed
Market Cap: 45.3B DKK

Relative Value

The Relative Value of one ALK B stock under the Base Case scenario is hidden DKK. Compared to the current market price of 223.8 DKK, ALK-Abello A/S is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALK B Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
14
vs Industry
23
Median 3Y
6
Median 5Y
6.7
Industry
2.6
Forward
7.7
vs History
74
vs Industry
11
Median 3Y
47
Median 5Y
57.1
Industry
21.7
Forward
42.3
vs History
77
vs Industry
16
Median 3Y
34.9
Median 5Y
46.5
Industry
16.6
vs History
25
vs Industry
3
Median 3Y
128
Median 5Y
104.1
Industry
22.5
vs History
23
vs Industry
12
Median 3Y
6.3
Median 5Y
7.1
Industry
2.3
vs History
15
vs Industry
22
Median 3Y
6
Median 5Y
6.7
Industry
2.9
Forward
7.7
vs History
25
vs Industry
24
Median 3Y
9.5
Median 5Y
10.7
Industry
5.5
vs History
57
vs Industry
16
Median 3Y
26.8
Median 5Y
29.4
Industry
13.1
Forward
24.6
vs History
66
vs Industry
16
Median 3Y
34.4
Median 5Y
40.4
Industry
16.6
Forward
29.5
vs History
77
vs Industry
17
Median 3Y
34.8
Median 5Y
47
Industry
15.8
vs History
26
vs Industry
6
Median 3Y
174.1
Median 5Y
185.1
Industry
19.1
vs History
7
vs Industry
18
Median 3Y
4.5
Median 5Y
5.1
Industry
1.9

Multiples Across Competitors

ALK B Competitors Multiples
ALK-Abello A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
ALK-Abello A/S
CSE:ALK B
50.1B DKK 8.2 45 28 33.8
US
Eli Lilly and Co
NYSE:LLY
929B USD 15.6 50.5 33.9 36.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
481.1B USD 5.2 19.2 15.7 20.4
CH
Roche Holding AG
SIX:ROG
251.1B CHF 4.1 26.6 11.4 13.3
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.8 29.8 108.1 158.2
CH
Novartis AG
SIX:NOVN
205B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
241B USD 3.8 12.7 9.1 10.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 9 10.4
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
144B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
DK
ALK-Abello A/S
CSE:ALK B
Average P/E: 25.4
45
24%
1.9
US
Eli Lilly and Co
NYSE:LLY
50.5
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.2
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.6
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
12.7
15%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
ALK-Abello A/S
CSE:ALK B
Average EV/EBITDA: 400.1
28
22%
1.3
US
Eli Lilly and Co
NYSE:LLY
33.9
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.7
9%
1.7
CH
Roche Holding AG
SIX:ROG
11.4
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.1
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.1
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
ALK-Abello A/S
CSE:ALK B
Average EV/EBIT: 1 710.5
33.8
25%
1.4
US
Eli Lilly and Co
NYSE:LLY
36.4
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.4
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.2
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.7
8%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
1%
10.4
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3